Cited by 359BRCA gene mutations in cancerDNA Repair MechanismsPARP inhibition in cancer therapy

The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.

Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line

Open access

Abstract

Retrovirally expressed, wild-type BRCA1 decreased the gamma radiation (IR) sensitivity and increased the efficiency of double-strand DNA break repair (DSBR) of the BRCA1-/- human breast cancer line, HCC1937. It also reduced its susceptibility to DSB generation by IR. By contrast, multiple, clinically validated, missense mutant BRCA1 products were nonfunctional in these assays. These data constitute the basis for a BRCA1 functional assay and suggest that efficient repair of double-strand DNA breaks is linked to BRCA1 tumor suppression function.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1097-2765(00)80238-5

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Cited by

Sorted by citations

See all 359

Metadata

Authors
Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., & Livingston, D. M.
Affiliations
  • Harvard University (US)
  • Massachusetts Institute of Technology (US)
Corresponding author
Livingston, David M
Venue
Molecular Cell
Publisher
Elsevier BV
Published
1999-12
Volume
4
Issue
6
Pages
1093-1099
ISSN
1097-2765 (ISSN-L)
OpenAlex
W1976960697
Cited by
359
References
45
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 13 · 2012: 13
FWCI
11.84
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (P01HL032262, HL-32262)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
BRCA1, DNA double-strand break repair, radiosensitivity, missense mutations, tumor suppression, retroviral gene expression, functional assays
MeSH terms
Breast Neoplasms, DNA Repair, Female, Genetic Vectors, Humans, Radiation Tolerance, Retroviridae, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Gene Transfer Techniques, BRCA1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review